AZD2281

olaparib · AstraZeneca

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for AZD2281, covering 2009-08-20 to 2018-07-05. Get the full timeline:

Most recent: Clinical Trial Update: AZD2281 and Cisplatin Plus Gemcitabine to Treat Solid Tumor Cancers [Phase 1]